Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
6 hedge funds and large institutions have $275K invested in Global Cord Blood Corporation in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 19 closing their positions.
74% less funds holding
Funds holding: 23 → 6 (-17)
89% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 19
99% less capital invested
Capital invested by funds: $30.4M → $275K (-$30.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$47K |
| 2 |
SPIA
Steward Partners Investment Advisory
New York
|
+$158 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$20.3M |
| 2 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$2.24M |
| 3 |
Renaissance Technologies
New York
|
-$702K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$526K |
| 5 |
Morgan Stanley
New York
|
-$260K |
CO Hedge Fund Activity: Q2 2023 in Review
6 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q2 2023, worth a combined $275K — down 99% from $30.4M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CO and 2 opened new positions — a net loss of 17 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was RhumbLine Advisers, opening a new position worth an estimated $47K. The largest seller was Oasis Management Company, exiting entirely with an estimated $20.3M sold.
- 6 institutional investors held Global Cord Blood Corporation (CO) as of Q2 2023, down from 23 in Q1 2023.
- Funds reported $275K of Global Cord Blood Corporation stock for Q2 2023, down 99% quarter-over-quarter.
- 2 funds opened new Global Cord Blood Corporation positions in Q2 2023 and 19 closed out, a net change of -17 holders.
- The largest Global Cord Blood Corporation buyer in Q2 2023 was RhumbLine Advisers, an estimated $47K added.
- The largest Global Cord Blood Corporation seller in Q2 2023 was Oasis Management Company, an estimated $20.3M sold.
Based on aggregated 13F filings for Q2 2023.